Crosstex Acquires NAMSA's Sterility Assurance Products Division

Crosstex Acquires NAMSA’s Sterility Assurance Products Division

Further Expands Sterility Assurance Portfolio and Broadens Market Diversification

HAUPPAUGE, NY – February 3, 2016 – Crosstex has entered into a definitive agreement with North American Science Associates, Inc. (NAMSA) to acquire their Sterility Assurance Monitoring Products division. This division manufactures a broad suite of high-quality biological and chemical indicators which are used to accurately monitor the effectiveness of sterilization processes. These indicators are designed primarily for the industrial segment serving medical device, life science and other manufacturers, representing a new end-market for Crosstex.

Gary Steinberg, President and CEO of Crosstex said, “This acquisition not only allows us to expand our sterility assurance product offering, but also broadens our presence into the important industrial market segment. We are also excited to provide additional product solutions to these customers with Crosstex’s complete infection prevention product portfolio.”

John Hughes, Vice President/General Manager of Crosstex/SPSmedical in Rochester, NY stated, “The addition of NAMSA’s Sterility Assurance Products Division expands our market position in the biological and chemical integrator market while strengthening our manufacturing capabilities through greater vertical integration.” Hughes went on to say, “We have retained the sales, marketing and customer care team which will allow for a seamless transition and provide our new customers with the same level of service and support they have been accustomed to receiving.”

Subject to customary closing conditions, the transaction is expected to close in the 3rd quarter of our Fiscal Year 2016.

# # #